Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial

Jean Fajadet(Clinique Pasteur), Sigmund Silber(Praxis für Humangenetik), Azfar Zaman(Royal Stoke University Hospital), Simon Elhadad, David Hildick‐Smith(Sussex County Community College), Sonia Petronio(Azienda Ospedaliera Universitaria Pisana), Thomas Hovasse(Hôpital Privé Jacques Cartier), Mariano Valdés(Universidad de Murcia), Mark Spence(Mater Private Hospital), David H. Roberts(University of Liverpool), Franz–Josef Neumann(La Jolla Alcohol Research), Jochen Wöhrle
EuroIntervention
January 1, 2017
Cited by 15


Related Papers